2024 ISV ANNUAL CONGRESS

SEOUL, SOUTH KOREA
Dragon City Hotel

21 – 23 October 2024

PROGRAM          ABSTRACT SUBMISSION          REGISTRATION          ACCOMMODATION          EXHIBITION & SPONSORSHIP          AWARDS

Dear ISV Members, Colleagues, and Friends,

We are thrilled to announce that the International Society for Vaccines (ISV) Annual Congress returns to Asia, October 21-23, 2024 at the Dragon City Hotel, Seoul, Korea. The International Vaccine Institute (IVI), established by the United Nations Development Programme is partnering with ISV for this important event.

The 2024 ISV Annual Congress welcomes vaccinologists from all disciplines of human and veterinary prophylactic and therapeutic vaccination and immunotherapy. Participants come from every discipline, including basic research, development, regulatory issues, manufacturing, and epidemiology and from all sectors, whether academic, industrial, governmental or non-governmental institutions.

Read more…

2024 Congress Chairs

Joon Haeng Rhee

Chonnam National University Medical School, South Korea

Margaret Liu

ProTherImmune, USA
Karolinska Institutet, Sweden

Shan Lu

UMASS Chan Medical School, USA

Ken Ishii

University of Tokyo, Japan

Jerome Kim

IVI – South Korea

Invited Speakers

(more to be added)

Peter Lawaetz Andersen

Novo Nordisk Foundation, Denmark

James Baber

Pfizer Vaccine Research and Development, Australia

Alejandra Capozzo

UAI, Argentina

Danilo Casimiro

Sanofi, USA

Corey Casper

AAHI, USA

Nam-Hyuk Cho

Seoul National University, South Korea

Seung Ho Choo

CREO SG Vaccine Institute, South Korea

Mark Connors

NIAID, HIV-Specific Immunity Section, USA

Simon Draper

University of Oxford, United Kingdom

Deborah Fuller

University of Washington School of Medicine

Sarah Gilbert

University of Oxford, United Kingdom

Cyril Guyard

BIOASTER, France

Brittany L. Hartwell

University of Minnesota, USA

SungHee Hong

SK bioscience Co., Ltd., South Korea

Joseph Jardine

Scripps Research Institute, USA
Andreas Holm Mattsson

Hong Jin

Blue Lake Biotechnology, USA
Andreas Holm Mattsson

Jerome Kim

International Vaccine Institute (IVI), South Korea
Andreas Holm Mattsson

Shee-Eun Lee

Chonnam National University, South Korea

Leyuan Ma

University of Pennsylvania, USA
Andreas Holm Mattsson

Andreas Holm Mattsson

Evaxion, Denmark

Dal-Hee Min

Lemonex/SNU, South Korea

Moon Nahm

University of Alabama at Birmingham, USA

Nicaise Ndembi

Africa Centres for Disease Control and Prevention (Africa CDC), Ethiopia

Albert Osterhaus

University of Veterinary Medicine Hannover (TiHo), Germany

Sallie Permar

Cornell University, USA

Angie Rasmussen

University of Saskatchewan, Canada

Nina Russell

Gates Foundation, USA

Kaku Saito

Moderna, Japan

Yoshimasa Takahashi

National Institute of Infectious Diseases, Japan

Axel Timmermann

Pusan University, South Korea

Birgit Weinberger

University of Innsbruck, Austria

Tao Zhu

CanSino Biologics, China

2024 Scientific Committee

– CO-CHAIRS-

David Weiner, The Wistar Institute – USA

Alexander Bukreyev, University of Texas Medical Branch – USA
Kimberly Matheson, Sanofi Canada – Canada
Pervin Anklesaria, Bill & Melinda Gates Foundation – USA
Jason McLellan, University of Texas, Austin – USA
Neil Almond, MHRA – UK
Jacqueline Miller, Moderna – USA
Annaliesa Anderson, Pfizer – USA
Peter Openshaw, Imperial College – London
Danilo Casimiro, Aeras – USA
Clarisa, Palatnik de Sousa, Federal University of Rio de Janeiro – Brazil
Hualan Chen, National Avian Influenza Reference Laboratory – China
Sanjay Phogat, GSK – Italy
Zhiwei Chen, Hong Kong University – China

Punnee Pitisuttithum, Mahidol University-Thailand

Andrew Pollard, Oxford Vaccine Group – UK
Mark Connors, NIH – USA
Gi-eun Rhie, Vaccine Research Center KDCA/KNIH – South Korea
David Salisbury, UK Department of Health (and WHO) – UK
Maria Elena Botazzi, Baylor – USA
Ann Ginsberg, Bill & Melinda Gates Foundation – USA
Manki Song, IVI – South Korea
Hoon Kim, SK bioscience – South Korea
Frederic Tangy, Institut Pasteur – France
Baik Lin Seong, University – South Korea
Petro Terblanche, Afrigen Biologics & Vaccines – South Africa
Anna Lise, Williamson, University of Cape Town – South Africa
Karin Loré, Karolinska Institutet – Sweden
Kapil Maithal, Vaccine Technology Centre – India

ISV Annual Supporters

Diamond Sponsors

Gold Sponsors

Silver Sponsors

The International Society for Vaccines is an organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines and immunotherapeutics.  The ISV is a global not-for-profit organization that aims to encourage, establish, and promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.
info@isv-online.org  /  ISV Annual Congress